Retracted on Nov 13, 2024. Do not cite it as support.
Source: Retraction Watch, via Crossref · checked Oct 31, 2026 · Read the notice
- Expression of concern published on Jan 31, 2022. Source: Retraction Watch, via Crossref · Read the notice
Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats
Nady Braidy, Gilles J. Guillemin, Hussein Mansour and 3 more
PLoS ONE · 2011
doi:10.1371/journal.pone.0019194
Abstract
The cofactor nicotinamide adenine dinucleotide (NAD+) has emerged as a key regulator of metabolism, stress resistance and longevity. Apart from its role as an important redox carrier, NAD+ also serves as the sole substrate for NAD-dependent enzymes, including poly(ADP-ribose) polymerase (PARP), an important DNA nick sensor, and NAD-dependent histone deacetylases, Sirtuins which play an important role in a wide variety of processes, including senescence, apoptosis, differentiation, and aging. We examined the effect of aging on intracellular NAD+ metabolism in the whole heart, lung, liver and kidney of female wistar rats. Our results are the first to show a significant decline in intracellular NAD+ levels and NAD:NADH ratio in all organs by middle age (i.e.12 months) compared to young (i.e. 3 month old) rats. These changes in [NAD(H)] occurred in parallel with an increase in lipid peroxidation and protein carbonyls (o- and m- tyrosine) formation and decline in total antioxidant capacity in these organs. An age dependent increase in DNA damage (phosphorylated H2AX) was also observed in these same organs. Decreased Sirt1 activity and increased acetylated p53 were observed in organ tissues in parallel with the drop in NAD+ and moderate over-expression of Sirt1 protein. Reduced mitochondrial activity of complex I-IV was also observed in aging animals, impacting both redox status and ATP production. The strong positive correlation observed between DNA damage associated NAD+ depletion and Sirt1 activity suggests that adequate NAD+ concentrations may be an important longevity assurance factor.
Full text
We don’t show the text of a retracted or withdrawn paper. The record stays, so citations to it can be checked.
References 80
- 1.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 2.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 3.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 4.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 5.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 6.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 7.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 8.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 9.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 10.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 11.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 12.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 13.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 14.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 15.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 16.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 17.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 18.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 19.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 20.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 21.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 22.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 23.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 24.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 25.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 26.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 27.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 28.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 29.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 30.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 31.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 32.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 33.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 34.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 35.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 36.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 37.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 38.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 39.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 40.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 41.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 42.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 43.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 44.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 45.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 46.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 47.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 48.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 49.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 50.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 51.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 52.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 53.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 54.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 55.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 56.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 57.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 58.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 59.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 60.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 61.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 62.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 63.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 64.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 65.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 66.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 67.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 68.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 69.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 70.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 71.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 72.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 73.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 74.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 75.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 76.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 77.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 78.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 79.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
- 80.
This reference’s wording can’t be shown under the paper’s licence.
Not in our library
Cited by papers we hold 24
- Regulation of SIRT1 and Its Roles in Inflammation · 2022No notice
- Mechanisms of impaired mitochondrial homeostasis and NAD+ metabolism in a model of mitochondrial heart disease exhibiting redox active iron accumulation · 2021Not checked
- NAD+ metabolism, stemness, the immune response, and cancer · 2021No notice
- Role of NAD+ in regulating cellular and metabolic signaling pathways · 2021No notice
- Oxidative Stress in Cognitive and Epigenetic Aging: A Retrospective Glance · 2020No notice
- DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation · 2019No notice
- Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD+ synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry. · 2019Not checked
- Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies · 2019No notice
- The Plasma NAD + Metabolome Is Dysregulated in “Normal” Aging · 2019No notice
- Sirt1–hypoxia‐inducible factor‐1α interaction is a key mediator of tubulointerstitial damage in the aged kidney · 2019No notice
- Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging · 2019No notice
- Mitochondria in the signaling pathways that control longevity and health span · 2019No notice
- NAD+ biosynthesis, aging, and disease · 2018No notice
- High Levels of SIRT1 Expression as a Protective Mechanism Against Disease-Related Conditions · 2018No notice
- The emerging role of alternative splicing in senescence and aging · 2017No notice
- Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells · 2017No notice
- Sirtuins, a promising target in slowing down the ageing process · 2017No notice
- Emerging therapeutic roles for NAD + metabolism in mitochondrial and age‐related disorders · 2016No notice
- Sirtuin Functions in Female Fertility: Possible Role in Oxidative Stress and Aging · 2015No notice
- A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in human. · 2015Not checked
and 4 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.